Loading viewer...
investor_presentation
Format: PDF investor_presentation
Natera presents its cell-free DNA technology platform and commercialization progress across oncology, women's health, and organ health markets at the J.P. Morgan Healthcare Conference. The company has processed over 10 million tests, launched 12 products, and expanded to more than 3,200 employees with preliminary 2023 financial results included.
earnings
17 Pages
investor_presentation
CarGurus
UOB Group Financial Performance June 2024
investor_presentationinvestor_presentation
55 Pages
United Overseas Bank Limited